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Abstract 
 Refeeding Hypophosphatemia (RH) is the most common complication of nutritional 
restoration during medical hospitalization for individuals with anorexia nervosa (AN).  
Characterized by a drop in serum phosphorus levels, consequences of RH can be seen throughout 
the body and are potentially life threatening.  Despite the seriousness of this outcome, little is 
known about which individuals with AN are at greatest risk of developing RH and best practices 
for prevention.  The purpose of this retrospective cohort study was to examine demographic, 
feeding, and biochemical factors found in hospitalized adolescent and young adults (AYA) 
diagnosed with AN that may contribute to the development of RH.  Individuals diagnosed with 
AN who were admitted to Boston Children’s Hospital between the years of 2010-2016 were 
considered for inclusion.  Three hundred charts were analyzed using logistic regression to 
determine factors associated with RH and multivariate regression to determine factors associated 
with serum phosphorus nadir.  In the final logistic regression model, receiving nasogastric tube 
feeding (p=0.54), age at admission (p=.022), weight gain during hospitalization (p=.003), serum 
potassium level (p=.001), and serum magnesium level (p=.024) significantly contributed to the 
model.  Odds of RH were 3 times higher in those who received NG feeding, 1.2 times higher for 
each year of increasing age, 1.5 times higher for each kilogram of weight gain, 9.2 times higher 
for each unit reduction in potassium, and 13.7 times higher for each unit reduction in 
magnesium.  With regards to phosphorus nadir, 1-unit increase in magnesium resulted in 1.2 
 
 
increase in phosphorus, and each unit of admit BMI increased phosphorus by .060.  The results 
indicate that NG feeding, age, weight gain, electrolyte abnormalities, and admit BMI are 
potential indicators of development of RH in AYA hospitalized with AN.  This study will inform 
clinicians of risk factors associated with RH, and may guide further investigation into the clinical 
management of AYA diagnosed with AN. 
 
Keywords: anorexia nervosa, feeding and eating disorders, hypophosphatemia, adolescent, young 
adult, refeeding syndrome 
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 This chapter details the problem of anorexia nervosa (AN), with focus on the 
development of refeeding hypophosphatemia in adolescents and young adults (AYA) diagnosed 
with AN. The purpose of the study, research questions, and assumptions based on existing 
knowledge are outlined.  The significance of this project with regards to the care for individuals 
with AN is addressed. 
Statement of the Problem 
 Anorexia Nervosa (AN) is a serious psychiatric illness characterized by energy restriction 
resulting in significantly low body weight, intense fear of weight gain, behavior that inhibits 
weight gain, body image disturbance, and undue influence of self-worth on body weight and 
shape (American Psychiatric Association [APA], 2013).  Care for individuals with AN occurs 
across medical and psychiatric clinical settings of varying intensity dependent on the case (APA, 
2013).  Medical hospitalization is required in cases of sustained fasting (food refusal), vital sign 
instability, electrolyte imbalance, precipitous weight loss, and signs of organ damage (American 
Academy of Pediatrics [AAP], 2003; American Dietetic Association [ADA], 2001; APA, 2006; 
Golden, et al., 2003).  During medical hospitalization, reintroduction of nutrition is a key 
component of care.  One of the most critical complications of this nutritional restoration period is 
refeeding syndrome.   
Refeeding syndrome is a potentially fatal condition that occurs due to electrolyte and 
fluid shifts when nutrition is reintroduced to the starved person (Fuentebella & Kerner, 2009).  
Refeeding hypophosphatemia (RH), a hallmark of impending refeeding syndrome, is the most 
common complication associated with nutritional restoration in severely malnourished 
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individuals with AN (Skipper, 2012).  Although a lower percent of median body weight 
(%mBMI) on admission has been associated with higher likelihood of developing RH (O’Connor 
& Nicholls, 2013), contributing individual factors and clinical interventions remain unknown.  
Therefore, there exists a lack of consensus among providers on best approaches to provide 
nutritional restoration while preventing RH (Bross, Shah, & Kopple, 2017; O’Connor & 
Nicholls, 2013).  Currently there is wide variability in approaches to nutritional restoration as 
well as phosphorous supplementation during the refeeding phase (Schwartz, Mansbach, Marion, 
Katzman, & Forman, 2008).  
The prediction of who is at greatest risk of RH remains poorly understood.  Initial serum 
phosphorous levels are likely to be within normal limits (O’Connor & Nicholls, 2013), making 
admission laboratory surveillance insufficient for identifying potential cases of RH during the 
medical hospitalization.  Additionally, serum concentrations of phosphorous on admission may 
not accurately predict total body phosphorous depletion that may lead to RH (Winston, 2012), 
and although phosphorous nadir occurs in the first week of hospitalization for over 80% of 
individuals during nutritional restoration, nadir may not occur for up to 20% of the population 
until up to day 24 (Orenstein et al., 2003).  Additionally, incidence of RH in adolescents and 
young adults (AYA) has been reported to be as high as 38%, with an average incidence of 14% 
(O’Connor & Nicholls, 2013).  Therefore, improved identification of those at greatest risk for the 
development of RH is imperative for improving clinical care in this population. 
Purpose of Study 
The purpose of this retrospective cohort study is to identify individual factors and clinical 
interventions that contribute to the development of RH for adolescents and young adults 
admitted to a general medical unit with AN.  The analysis will examine the hypothesis that there 
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is no association between factors identified in AYA with AN who develop RH and those who do 
not.   
Research Questions 
1.  What factors are associated with the development of RH for AYA with AN during 
medical hospitalization? 
2. How do the factors of interest influence the level of serum phosphorus in this population 
during medical hospitalization? 
Definition of Terms 
Anorexia Nervosa: Diagnosable mental illness defined in the Diagnostic and Statistical Manual 
of Mental Disorders, Fifth Edition as “persistent energy intake restriction, intense fear of gaining 
weight or becoming fat, or persistent behavior that interferes with weight gain; and a disturbance 
in self-perceived weight or shape.” (APA, 2013, p. 339).  Further sub-classified into restricting 
type and binge-eating/purging subtypes, with key defining feature between these groups is 
presence or absence of recurrent binge-eating and purging behaviors within the last three months.  
 
Adolescence: Period of development during which individuals achieve sexual maturation and 
undergo significant growth and development both mentally and physically.  This time in the 
lifespan is at risk for development of a number of maladaptive behaviors and disorders, including 
AN.  Although onset of physical and sex organ maturation varies between sexes and individuals, 
commonly used numerical age cutoffs for adolescents is 10-19 years of age (World Health 
Organization, 2015). 
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Young Adulthood: Period of the human lifespan between adolescence and adulthood, 
characterized by life processes such as increasing independence and job/career establishment.  
Although age cutoffs for young adulthood varies in the literature, for the purposes of this study 
will be defined as 20-24 years of age, consistent with published literature on risk behavior in the 
area (Lewinsohn, Rohde, Seeley, & Baldwin, 2001). 
 
Phosphorous: An essential body mineral necessary for energy production in the form of ATP, a 
component of human DNA, and an acid-base buffer in human blood.  Phosphorous is not 
produced endogenously, but rather is consumed through nutritional intake and primarily stored 
intracellularly within the body.  
Assumptions Based on Existing Knowledge 
1. Adolescents and young adults with AN are at risk for RH. 
2. Early identification of RH is critical to the care of adolescents and young adults with AN. 
3. Nutritional restoration is a primary goal of inpatient medical hospitalization for 
individuals with AN. 
Conceptual Framework 
The development of RH is due to the increased production of energy in the form of 
adenosine triphosphate (ATP) and 2,3-diphosphoglycerate (DPG) as well as a subsequent insulin 
surge that results in the increased cellular reuptake of serum phosphorus in malnourished 
individuals.  However, factors within the AYA with AN that impact the development of RH 
within this context remain unknown.  Figure 1 illustrates the development of RH in starvation, 
Figure 2 represents the model of RH for AYA with AN that will be used to guide this research. 
 




Significance of Project 
This study will generate new knowledge on the relationship between factors that are 
associated with development of RH in AYA with AN.   The findings may be used to identify risk 
and to inform interventions that include individualized care plans for the prevention and 
management of RH, including appropriate phosphorous supplementation.   Furthermore, results 
may guide clinicians in development of standard protocols and consensus statements on the risk, 
prevention, and management of RH in this population. Improved prevention and management of 
RH during medical admission may facilitate timelier transfer to needed psychiatric care for this 



















Review of the Literature 
 This chapter reviews the literature pertaining to factors that influence the development of 
RH in AYA with AN during medical hospitalization.  This diagnosis of AN will be outlined with 
regards to epidemiology, medical complications and co-morbidities.  A review of refeeding 
syndrome and RH will be explored.  Specific variables of concern include demographic factors 
including weight/body mass index, weight loss prior to admission, age, and sex will be outlined.  
In addition, feeding variables including initial caloric prescription and feeding route will be 
reviewed. Finally, biochemical variables of interest include bradycardia, serum potassium level, 
serum magnesium level, and elevated resting energy expenditure related to anxiety and 
psychiatric distress will be examined.  
Anorexia Nervosa 
 First described by Richard Morton in 1859 and termed “anorexia nervosa” in 1873 by Sir 
William Gull (Pearce, 2004), AN is a chronic psychiatric illness in which individuals inhibit 
weight gain through restrictive intake, and in some cases use compensatory mechanisms in an 
effort to avoid weight gain (APA, 2013).  AN affects 0.3-2.2% of of the population (Hudson, 
Hiripi, Pope, & Kessler, 2007; Smink, van Hoeken & Hoek, 2012), with the peak age of onset 
occurring during adolescence and young adulthood (median 12.3 years; Swanson, Crow, 
LeGrange, Swendsen, &Merikangas, 2011).  There are significant psychiatric and physiologic 
consequences associated with AN; specifically, AN has been shown to have high mortality rates 
relative to the population (Birmingham, Su, Hlynsky, Goldner, & Gao, 2005; Papadopoulos, 
Ekbom, Brandt, & Eselius, 2009), and is suggested to have the highest mortality rate among all 
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mental illnesses (Arcelus, Mitchell, Wales & Nielsen, 2011; Harris & Barraclough, 1998) with 
one in five individuals with AN suffering death by suicide (Arcelus et al., 2011).    
AN is classified into two subtypes: restricting subtype (AN-R), representing those who 
do not binge eat or purge, and binge eating/purging subtype (AN-B/P), those who report binge 
eating and purging behavior at least weekly (APA, 2013).  In a case report of a low weighted 
individual, binge eating behavior precipitated hypophosphatemia in itself (Kaysar, Kronenberg, 
Polliack, & Gaoni, 1991).  Purging through the abuse of laxatives or diuretics may influence 
hypophosphatemia through electrolyte loss during such episodes (Winston, 2012).  With regard 
to illness severity, those with AN-B/P are more likely to relapse (Carter et al., 2012), which may 
represent more severe illness than those with AN-R. 
Medical Complications of AN 
 AN is associated with a number of medical complications, stemming from malnutrition 
and compensatory mechanisms to inhibit weight (Monge & Loh, 2018).  Physical effects can be 
seen throughout the body.  Some physical effects, such as vital signs or amenorrhea, may resolve 
with weight restoration, while effects such as low bone mineral density may not (Westmoreland, 
Kantz, & Mehler, 2016).  More commonly seen consequences include cardiovascular 
compromise (bradycardia, hypotension, arrhythmias), endocrine abnormalities (amenorrhea, 
euthyroid) and gastrointestinal disturbances (constipation, diarrhea, delayed gastric emptying) 
and others (Wolfe, Dunne, & Kells, 2016).  A summary of medical complications in AN can be 
found in Table 1. Medical hospitalization for individuals with AN is necessary when an 
individual exhibits unstable vital signs, or is unable to take food orally, has signs of organ 
damage, alterations in serum electrolytes, or rapid weight loss (AAP, 2003; ADA, 2001; APA 
2003; Golden, et al., 2003).  




Table 1.   
Medical complications of AN 
System Signs and Symptoms 
Cardiovascular Bradycardia, hypotension, orthostasis, arrhythmias, 
electrocardiogram abnormalities, sudden death associated with 
prolonged W-T interval and arrhythmias 
Dermatologic Xerosis, acrocyanosis, brittle hair and nails, hair loss, lanugo, 
loss of subcutaneous fat 
Endocrine Amenorrhea or ogliomenorrhea, hypoglycemia, alterations in 
sex hormones, hypothermia, cold intolerance 
Fluid and Electrolytes Dehydration, peripheral edema 
Gastrointestinal 
 
Constipation, diarrhea, bloating, gastric distention, delayed 
gastric emptying, superior mesenteric artery syndrome 
Hematology Bone marrow suppression, anemia, leukopenia, neutropenia, 
thrombocytopenia, decreased albumin 
Musculoskeletal Fractures, osteoporosis, osteopenia 
Neurologic Depression, syncope, brain atrophy, fatigue 
Pulmonary Pulmonary edema 
Note: Adapted from “Nursing care considerations for the hospitalized patient with an eating 
disorder” by B.E. Wolfe, J.P. Dunne, & M.R. Kells, 2016, Nursing Clinics of North America, 51, 
p. 218. 
 
Co-morbid Psychiatric Diagnoses 
High rates of co-morbid psychiatric disorders are reported among individuals with AN 
(Ulvebrand, Birgegard, Norring, Hogdahl, Von Hausswolff-Juhlin, 2015) with some articles 
describing up to 97% of individuals experiencing at least one in their lifetime (Blinder, Cumella 
& Sanathara, 2006).  Of those, mood disorders, anxiety, obsessive-compulsive are most common 
(Hudson, Hiripi, Pope & Kessler, 2007; Swanson, Crow, Legrange, Swendsen & Merikangas, 
2011) 
Evidence points to an increased prevalence of all types of anxiety disorders including 
social phobia, obsessive compulsive disorder (OCD), generalized anxiety disorder (GAD), 
agoraphobia, panic disorder, simple phobia, and post-traumatic stress disorder (PTSD), in 
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individuals diagnosed with AN compared to healthy controls (Godart, Flament, Perdereau, & 
Jeammet, 2002).  Reports indicate that as many as 72% of individuals with AN are diagnosed 
with at least one anxiety disorder in their lifetime (Godart et al., 2002).   
Refeeding Syndrome and Refeeding Hypophosphatemia 
Phosphorous  
Phosphorus is a mineral that is derived solely from dietary sources (Gropper & Smith, 
2013), is found in an abundance of food sources (Anderson & Dempster, 2017; Boyle & 
Goldfarb, 2017; Heaney, 2012), with high quantities found in dairy products, meat, seafood, and 
nuts.  It is widely found throughout the human body (Boyle & Goldfarb, 2017; Heaney, 2012; 
Hruska, 2017) and is implicated in bone development, as a component of RNA and DNA, 
utilized in energy metabolism, is a major component of cellular wall function, and aids in 
maintaining serum pH (Anderson & Dempster, 2017; Boyle & Goldfarb, 2017; Gropper & 
Smith, 2013; Heaney, 2012; Raffi & Razzaque, 2017).  Digestion of phosphorus occurs through 
absorption in the intestine (Boyle & Goldfarb, 2017; Gropper & Smith, 2013; Hruska, 2017), and 
enters the blood approximately one-hour post dietary ingestion (Gropper & Smith, 2013).  
Phosphorus absorption in the small intestine is mediated by available Vitamin D (Hruska, 2017).  
The relationship between dietary intake of phosphorus and the absorption of the mineral is linear 
(Hruska, 2017):as intake of the mineral goes up, so does absorption.  Excessive intake of phytic 
acid, magnesium, aluminum and calcium may inhibit absorption of phosphorus, however this is 
limited to individuals who receive high doses of antacids or calcium, aluminum, and magnesium 
compounds (Boyle & Goldfarb, 2017; Gropper & Smith, 2013).  
Phosphorus is filtered through the glomeruli of the kidneys, with up to 80-90% 
reabsorption rate in the renal tubules and increased reabsorption when phosphorus intake is 
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deficient in the diet (Boyle & Goldfarb, 2017; Heaney, 2012; Hruska, 2017).  Ultimately, 
intestinal intake and urine excretion achieve a net balance (Heaney, 2012).  Phosphorus is stored 
in bone, controlled in part through the action of the parathyroid hormone (PTH) and fibroblast 
growth factor-23 (FGH-23), which regulate bone resorption, movement of both calcium and 
phosphorus from bone to serum fluids, and renal excretion of excess phosphorus to maintain 
optimal health (Anderson & Dempster, 2017; Heaney, 2012).  Bone loss and formation is 
constantly in flux in relationship to dietary intake of phosphorus (Anderson & Dempster, 2017).   
In adult serum, the normal range of phosphorus concentration is 2.5-4.5 mg/ld., with nadir levels 
of the mineral occurring the morning between 8 and 11 am (Hruska, 2017). Since phosphorus 
cannot be made endogenously, individuals who do not consume adequate nutrition (i.e., those in 
starvation state as in individuals diagnosed with AN) will become depleted. Thus, phosphorus 
deficiency is a considered the hallmark indicator of risk for development of refeeding syndrome 
(Skipper, 2012). 
Refeeding Syndrome 
Refeeding syndrome is a constellation of clinical signs and symptoms that occur as a 
result of metabolic alterations during the reintroduction of nutrition to an individual after 
starvation state (Fuentebella & Kerner, 2009; Skipper, 2012).  What would later be termed 
“refeeding syndrome” was first described by Ancel Keys and associates at the University of 
Minnesota in 1944.  The Minnesota Experiment utilized conscientious war objectors as subjects 
to examine the effects of starvation.  In this study, thirty-six individuals were randomized to low 
calorie diets. After achieving significant weight loss, they were refed per protocol with or 
without vitamin and mineral supplements. During this period of renutrition, Keys documented 
various signs and symptoms of what is now known as refeeding syndrome, including 
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neurological deficits and peripheral edema (Kalm & Semba, 2005; Keys, Brozek, Henschel, 
Mickelsen, & Taylor, 1950).  
Several years later, Schnitker, Mattman, & Bliss (1951) outline the effects of malnutrition 
on Japanese prison camp detainees in the Philippine Islands in 1945.  In this paper, the Allied 
medical doctors provided care to 24 of the most severely malnourished individuals out 8,000 
prisoners at the camp, consisting of a diet of 3,400 calories, yeast, thiamine, and ferrous sulfate 
supplementation and compared to 24 healthy Japanese controls.  The cases describe edema 
during refeeding in the majority of cases, dyspnea, palpitations, poor appetite, early satiety, 
abdominal pain, diarrhea.  Weight gain was reported to be “slow” and five of the 24 individuals 
died.  Since that time, the effects of starvation have been studied and described in a number of 
patient populations, and although proposed guidelines have been suggested (Stanga et al., 2007), 
a universal definition of the syndrome does not exist. 
During starvation, the body attempts to conserve energy by a reduction in basal metabolic 
rates, insulin secretion, and endogenous hormone production (Fuentebella & Kerner, 2009).  To 
produce energy on a reduced caloric intake, metabolic processes initially deplete fat stores, 
eventually turning to ketogenesis, and finally to protein catabolism, in turn producing lean body 
mass and organ atrophy (Bross, Shah, & Kopple, 2017; Fuentebella & Kerner, 2009).  During 
this starvation process, cellular supply of potassium, phosphate, and magnesium are depleted 
along with fat and protein loss (Bross, Shah, & Kopple; 2017).   When nutrition is reintroduced, 
the shift to carbohydrate anabolism occurs, and a demand for insulin to drive this process 
develops (Bross, Shah, & Kopple, 2017; Kraft, Ptaiche, & Sacks, 2005).  The surge in insulin 
production results in rapid cellular reuptake of glucose, potassium, magnesium, and 
phosphorous.  The urgent need for phosphorus causes a shift from bone storage of the mineral to 
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cells; however, if starvation induced low phosphorus levels exist prior to reintroduction of 
nutrition, the high demand for phosphorus is greater than that which bone stores may be able to 
supply (Boyle & Goldfarb, 2017).  Rapid cellular reuptake of phosphorus, along with the state of 
depleted total body storage of phosphorus during starvation, results in serum levels of the 
mineral dropping precipitously (Boyle & Goldfarb, 2017; Bross, Shah, & Kopple, 2017; Society 
for Adolescent Health and Medicine [SAHM], 2014).   
The clinical manifestations of refeeding syndrome are largely the result of underlying 
metabolic and electrolyte disturbances (Bross, Shah, & Kopple, 2017; Kraft et al., 2005).  
Therefore, consequences of this shift in metabolism can have effects in multiple organ systems 
and throughout the body.  These manifestations may include impaired cardiac function, 
respiratory failure, neurologic deficits, weakness, paralysis, seizures, arrhythmias, coma, tetany, 
encephalopathy, nausea, vomiting, constipation, pulmonary edema, lactic acidosis, fluid 
overload, and death (Kraft et al., 2005).  
 Refeeding syndrome is not unique to AN; however, this population is at great risk for 
developing this complication due to nutritional deficiency associated with the disease (Kraft et 
al., 2005).  Refeeding syndrome has been described in those at risk for chronic malnutrition, such 
as individuals diagnosed with inflammatory bowel disease (Akobeng & Thomas, 2010), post 
bariatric surgery (Silk, Jones, & Health, 2011; Vincent, Aylwin, & leRoux, 2009) postoperative 
patients (Geerse, Bindels, Kuiper, Roose, Spronk, & Schultz, 2010), and those in intensive care 
settings receiving intravenous fluids for extended periods of time without protein or calories 
(Geerse et al., 2010).   
 
 




Hypophosphatemia, or below normal levels of serum phosphorous, is the hallmark sign 
of refeeding syndrome (Kraft, Ptaiche, & Sacks, 2005; Skipper, 2012).  The development of 
hypophosphatemia is multi-factorial.  First, during a starvation state the individual becomes 
depleted of total body phosphorous levels.  With the reintroduction of nutrition, the little 
available extracellular phosphorous is driven intracellularly by a surge in insulin production for 
anabolism (Boyle & Goldfarb, 2017; Kraft et al., 2005).  Finally, the reintroduction of nutrition 
results in an increased demand for phosphorous as a part of glycolysis, or the production of 
adenosine triphosphate (ATP) and 2,3-diphosphoglycerate (DPG) necessary for bodily functions 
(Boyle & Goldfarb, 2017; Haglin, 2001; Kraft et al., 2005; Marinella, 2005).  
ATP is the primary energy source for all cells in the body (Kraft et al., 2005), and ATP 
and DPG are vital to a number of critical body processes (Boyle & Goldfarb, 2017).  Therefore, 
as a result of phosphorous depletion and impaired ATP and DPG production, a number of body 
systems can be affected.  Hypophosphatemia can contribute to the development of seizures 
(Silvas & Paragas, 1972), inhibited cardiac contractility and function (O’Connor, Wheeler, & 
Bethune, 1977), respiratory insufficiency (Aubier et al., 1985; Demirjian et al., 2011; Newman, 
Neff, & Ziporin, 1977), rhabdomyolysis, hemolysis, altered mental status, coma, and death 
(Kraft et al., 2005).  RH is the most common complication associated with nutritional restoration 
in severely malnourished individuals with AN (Skipper, 2012) and most commonly occurs 
within the first week of nutritional restoration (SAHM, 2014).  
There are no consensus guidelines to provide clinicians with an evidence-based approach 
to treatment of refeeding syndrome or RH (Boyle & Goldfarb, 2017; Bross, Shah, & Kopple, 
2017; O’Connor & Nicholls, 2013; Schwartz et al., 2008), or what what interval is most 
HYPOPHOSPHATEMIA IN AN   
 
15 
appropriate for electrolyte monitoring (Boyle & Goldfarb, 2017).  The literature reports several 
common approaches of treatment, including electrolyte replacement when low or deficient 
(Boyle & Goldfarb, 2017; Bross, Shah, & Kopple, 2017; Schwartz et al., 2008), prophylaxis, and 
treatment of declining trends.  It has been suggested that clear risk stratification to target 
individuals for whom intervention is warranted is the key fist step in treatment (Boyle & 
Godlfarb, 2017).  Correction of RH is typically either oral or intravenous, based on severity of 
deficit (Boyle & Goldfarb, 2017). 
Demographic Variables 
Weight and Body Mass Index 
 Weight is an important clinical consideration in the classification of the severity and the 
outcomes of treatment in adolescents with AN (SAHM, 2015).  In adolescents with AN, weight 
classification is best described in terms of the median body mass index (BMI), which is the 
weight in kilograms divided by the square of the height in inches (Centers for Disease Control 
and Prevention, 2016).  In this age range, median BMI (mBMI) is used as a means of 
incorporating the adolescent’s age and height as weight in absolute number changes according to 
these demographics (SAHM, 2015).    
 Weight is used as a treatment outcome and proxy measure in many aspects of care for 
individuals with AN.  It is used as a characteristic in the definition of recovery (Keski-Rahkonen, 
Raevuori, Bulik, Hoek, Rissanen, & Kapiro, 2014), has been shown to be predictive of favorable 
short-term clinical outcomes (Lund, Hernandez, Yates, Mitchell, McKee, & Johnson, 2009), the 
remission of symptoms of AN at the end of treatment (LeGrange, Accurso, Lock, Agras, & 
Bryson, 2014), and low weight on presentation has been associated with higher mortality rates 
(Arcelus et al., 2011).  Pre-morbid weight has been shown to predict weight at hospitalization 
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discharge, and in turn, weight at discharge predicts weight at 1-year follow up (Focker et al., 
2015).   Achievement of target weight is also predictive of resumption of menses in adolescents 
(Dempfle et al., 2013), which is a goal of treatment in this cohort (SAHM, 2015). With regards 
to psychological outcomes, weight gain improves eating disorder pathology, particularly if 
achieved earlier in treatment (Accurso, Ciao, Fitzsimmons-Craft, Lock & LeGrange, 2014).  
BMI, and mBMI as a more accurate indicator of weight in adolescents with AN, have 
been associated with hypophosphatemia in this cohort (Ornstein, Golden, Jacobson, & Shenker, 
2003).  O’Connor and Nicholls (2013) report a positive correlation between percent mBMI and 
phosphate nadir in a systematic review of RH in subjects with AN, with lower initial % mBMI 
associated with lower phosphate nadir (r2=0.6, p=0.01).  Golden, Keane-Miller, Sainani, and 
Kapphahn (2013) also showed an association between percent median body weight (%mBMI) on 
admission and hypophosphatemia rates during hospitalization (p=0.004) in a cohort of 
adolescents with AN. Whitelaw et al. (2010) reported a small sample chart audit of 46 
admissions that included 29 unique individuals aged 12-18. In this population, those with less 
than 68% Ideal Body Weight (IBW) were associated with a higher risk of RH, 38% of the 
admissions showed mild RH and no incidences of “moderate or severe” RH. 
Weight Loss Prior to Admission 
 Weight loss prior to admission is a clinical indicator of severity of illness (SAHM, 2015) 
and has been suggested as a link to the development of RH (Golden, Keane-Miller, Sainani, & 
Kapphahn, 2013; SAHM, 2014).  In a prospective study of adults with AN, weight loss of greater 
than 15% prior to admission had sensitivity value of 66.7% in predicting refeeding syndrome, 
defined, in part, by hypophosphatemia as well as other clinical factors such as hypokalemia, 
hypomagnesemia, peripheral edema, and end organ failure (Rio, Whelan, Goff, Reidlinger, & 
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Smeeton, 2012).  In a study of hospitalized adolescents with AN, Golden et al. (2013) found an 
association between hypophosphatemia and rate of weight loss prior to admission (ß=0.2; 
p=0.03). 
Age 
 The peak age of onset for AN occurs during adolescence (Birmingham, Su, Hlynsky, 
Goldner, & Gao, 2005; Papadopoulos, Ekbom, Brandt, & Eselius, 2009).  The highest incidence 
is among 15-19 year olds (Wentz, Gillberg, Anckarsater, Gillberg, & Rastam, 2012; Favaro, et 
al., 2009) and studies suggest that the age of onset has been decreasing over time (Favaro, 
Caregaro, Tenconi, Bosello, & Santonastaso, 2009). Halmi (2009) has suggested that earlier 
diagnosis of AN is on the rise.  Age at diagnosis is also significant, as earlier initial assessments 
(those less than 18 years of age compared to greater than 18 and adults) are associated with more 
favorable outcomes including improved mortality rates (Ackard, Richter, Egan, & Cronemeyer, 
2014; Arcelus et al., 2011).  Older adolescents have a lower BMI and longer duration of illness 
on admission compared to younger adolescents (Buhren et al., 2013), Conversely, in a small 
sample of individuals with AN Wentz, Gillberg, Anckarsater, Gillberg, and Rastam (2012) found 
that younger age was associated with poorer psychiatric functioning as measured by Global 
Assessment of Functioning (GAF). 
Sex 
While AN is predominantly diagnosed in females (Hoek & van Hoeken, 2003), the 
disorder does affect males.  However, there are differences noted in presentation, severity, and 
pathology in men.  Males report significantly more self-induced vomiting than females (Darcy, 
Doyle, Lock, Peebles, Doyle, & LeGrange, 2012) and may be more likely to diet because they 
were actually overweight at some point in their lives, as opposed to females who diet because 
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they perceive themselves to be overweight (Wooldridge & Lytle, 2012).  Also unlike females, 
males may have an increased focus on muscle mass, a condition known as “muscle dysmorphia”; 
however, both genders exhibit similarities in distorted body image, disordered eating, and 
excessive exercise behavior (Murray, Rieger, Hildebrandt, Karlov, Russell, Boon, Dawson, & 
Touyz, 2012). Some studies have shown that males self-report excessive exercise at significantly 
higher rates than females (Lewinsohn, Seely, Moerk, & Striegel-Moore, 2002). Like their female 
counterparts, males with AN develop endocrinologic consequences/dysfunction, including 
infertility, low levels of testosterone, Follicle Stimulating Hormone (FSH), Luteinizing Hormone 
(LH), and Luteinizing Hormone Releasing Hormone (LHRH), and are at risk for the 
development of osteoporosis (Wooldridge & Lytle, 2012).  
Feeding Variables 
 Nutritional rehabilitation is a primary goal of inpatient medical hospitalization for AYA 
with AN (SAHM, 2015).  Current protocol recommendations by the APA, ADA, and other 
authorities include a range of caloric prescriptions (ADA, 2006; APA, 2006) which have been 
suggested to be insufficient for adequate weight gain (Garber et al., 2013; Golden, Keane-Miller, 
Sainani, & Kapphahn, 2013; Katzman, 2012; LeGrange, 2013; Redgrave et al., 2015; Whitelaw, 
Gilbertson, Lam, & Sawyer, 2010).  Mealtime procedures are of particular interest to clinicians 
as the need for psychiatric support for this vulnerable population is often greatest during meals 
(Kells et al., 2016; Long, Wallis, Leung, Arcelus, & Meyer, 2012).  The development of RH 
occurs within the setting of nutritional rehabilitation; therefore, the examination of feeding 
protocols is a significant component of the discussion of this serious condition. 
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Initial Caloric Prescription  
 In a literature review of reports of refeeding syndrome in children and adolescents with 
AN published by O’Connor and Nicholls (2013), the mean starting rate of caloric intake in cases 
that developed refeeding syndrome was 27 kcal/kg; however, a wide range of suggested 
refeeding guidelines which included rates from 10 to 60 kcal/kg were reported (O’Connor & 
Nicholls, 2013).  This review highlighted that even with very conservative approaches utilized to 
initiate refeeding, individual patients were still at high risk for the development of refeeding 
syndrome.   
A widely accepted, long-standing approach to prevention of refeeding syndrome or RH 
was the concept of “start low, go slow”, with an initial low caloric rate and incremental increase 
over a period of time such as 4-10 days (Boyle & Goldfarb, 2017).  In a systematic review of 
RH, the studies with the highest initial feeding rates had the highest incidence (O’Connor & 
Nicholls, 2013).  Interestingly, studies that reported low initial refeeding rates also reported the 
development of RH (O’Connor & Nicholls, 2013); yet, in the final analysis, no correlation was 
noted between refeeding rate and the development of RH (r=0.21, p=0.7).  One study (Leclerc, 
Turrini, Sherwood, & Katzman, 2013) describes a structured nutritional programs starting at 
1500 kcal/day with a relatively low incidence (3.5%) of RH with steady weight gain (Leclerc, 
Turrini, Sherwood, & Katzman, 2013).  However, a number of researchers have argued that 
initial inpatient feeding regimens are too conservative to support adequate weight gain, and more 
aggressive feeding regimens have been recommended (Garber et al., 2016; Garber, Michihata, 
Hetnal, Shafer, & Moscicki, 2012; Whitelaw, Gilbertson, Lam, & Sawyer, 2010; SAHM, 2015). 
 
 




 Due to the underlying psychiatric nature of AN, extreme fear of weight gain, and 
gastrointestinal symptomology that may occur during initial nutritional restoration, oral 
consumption of calories is not always possible.  In these cases, as well as other situations where 
the need to promote weight gain exists, short-term nasogastric (NG) tube feedings to deliver 
meal replacement formula such as Ensure© or Ensure Plus© may be utilized (AAP, 2003; ADA, 
2001; APA, 2006; Golden et al., 2003) and has been suggested to be useful to provide higher 
amounts of calories than individuals may be able to consume orally (Garber et al., 2016).   
In a systematic review of NG feeding in individuals with AN reported by Rizzo, Douglas 
and Lawrence (2018), studies included showed a less than 1% incidence of RH in those fed via 
NG tube, with no cases of refeeding syndrome. An integrative review of NG feedings in 
individuals diagnosed with AN described six studies of examples of resultant RH in NG fed 
patients (Kells & Kelly-Weeder, 2016). For those examining a cohort of NG fed participants 
only, Georges et al. (2004) reported one case of severe hypophosphatemia after a 1.2 kg weight 
gain.  Bufano et al. (1990) also described three participants who developed hypophosphatemia 
two weeks into treatment.  Gentile, Pastorelli, Ciceri, Manna, and Collimedaglia (2010) reported 
hypophosphatemia in 35% of participants on admission, all of which resolved at 30 and 60 days. 
 When comparing NG versus orally (PO) fed participants, few studies have reported 
serum chemistry values related to refeeding syndrome.  Agostino, Erdstein, and DiMeglio (2013) 
and Rigaud et al. (2007; 2011) reported no refeeding syndrome for either NG or PO groups; 
however, in a separate study Agostino and colleagues (2013) reported four cases of RH in the PO 
group, while no cases were found in the NG fed group.  
 





 Weight loss in AN results in reduced vagal tone which contributes to bradycardia, a 
common symptom in severely malnourished individuals with AN (Westmoreland et al., 2016)). 
The degree of bradycardia is a clinical indicator of severity of malnourishment (Galetta et al., 
2003). Recent studies have indicated that rate of weight loss is a more accurate predictor of 
bradycardia than mBMI on admission, suggesting that bradycardia may be a useful clinical tool 
to indicate degree of malnutrition in individuals with higher weights (DiVasta et al., 2010; 
Garber, Lee, Benedict, Buckelew, & Moscicki, 2015).  In addition to malnutrition-induced 
bradycardia, severe hypophosphatemia can also impair cardiac function, resulting in reduced 
stroke volume, mean arterial pressure, and left ventricular stroke work reductions, as well as 
increases in pulmonary artery wedge pressures (O’Connor et al., 1977).  Currently, there are no 
studies that have examined the relationship between degree of bradycardia and development of 
RH in AYA with AN. 
Blood Pressure 
 Hypotension and postural changes in blood pressure (orthostatic hypotension) are 
commonly found medical complications in AYA with AN (Palla & Litt, 1988; Rosen, 2010; 
Takimoto, Yoshiuchi, Ishizawa, Yamamoto, & Akabayashi, 2014) and are accepted parameters 
of medical instability necessitating medical hospitalization in this population (SAHM, 2015).   
When compared with healthy controls, adolescent females with AN demonstrate lower baseline 
blood pressure (Mirsa et al., 2004) that, unlike bradycardia, may not resolve with nutritional 
restoration (Shamim, Golden, Arden, Filiberto, & Shenker, 2003).  
 




 Similar to phosphorous, starvation results in total body potassium depletion.  After the 
reintroduction of nutrition, an insulin surge results in a cellular reuptake of potassium that leads 
to serum hypokalemia (Fuentebella & Kerner, 2009; Kraft et al., 2005).  Hypokalemia has been 
used as a diagnostic factor in defining refeeding syndrome (Rio et al., 2012) and studies in adult 
patients have shown hypokalemia as a predictor of RH (Brown, Sabel, Guadiani, & Mehler, 
2015).  
Magnesium 
 As with phosphorous and potassium, starvation results in total body depletion of 
magnesium, as well as a subsequent increase in cellular reuptake of magnesium during the 
reintroduction of nutrition (Fuentebella & Kerner, 2009; Kraft et al., 2005).  Magnesium is a key 
component of the sodium-potassium ATPase pump; therefore, hypomagnesemia can inhibit 
potassium repletion (Kraft et al., 2005) and is associated with hypokalemia (Winston, 2012). 
Intake of magnesium is often low prior to treatment; and therefore, hypomagnesemia may 
develop prior to or during the refeeding process (Winston, 2012). In a recent study of inpatient 
adults, low baseline magnesium levels independently predicted the development of refeeding 
syndrome (p=.021; Rio et al., 2012) 
Hemoglobin 
 The hematologic consequences of AN include bone marrow suppression and resultant 
anemia (Mirsa et al., 2004).  However, Brown and colleagues (2015) investigated a sample of 
adult patients with AN and reported that higher levels of hemoglobin were associated with 
greater odds of RH (OR=1.56).  A possible contributing factor may be hemoconcentration 
related to dehydration or the use of phosphorous in the formation of hemoglobin itself (Brown et 
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al., 2015).  There are no studies to date that have evaluated the relationship between hemoglobin 
and RH in AYA with AN. 
Energy Expenditure and Psychiatric Functioning 
As outlined above, weight gain and nutritional rehabilitation are of critical importance in 
the treatment of individuals with AN.  To that end, the topic of resting energy expenditure (REE) 
has been investigated in an attempt to elucidate factors that may influence weight gain patterns 
and specific caloric prescriptions for this cohort.  REE is defined as the body’s energy 
requirement to fulfill basic physiologic functions while at rest (Castellini et al., 2014).  
Generally, REE is reduced in individuals with AN compared to healthy controls. This is related 
to the adaptive state of energy conservation that develops in response to the chronic malnutrition 
associated with AN (Kosmiski, Schmiege, Mascolo, Guadiani, & Mehler, 2014).  However, 
psychological factors also appear to influence REE in individuals with AN.  Anxiety levels were 
found to be positively correlated with resting energy expenditure (higher levels of anxiety 
associated with higher REE), while depressive states were reported to be negatively correlated 
with resting energy expenditure, or that higher depressive state was associated with lower REE 
(Van Wymelbeke, Brondel, Brun, & Rigaud, 2004). Castellini and associates (2014) reported 
that psychological distress and lower BMI have been associated with higher rates of REE.  
Cellular reuptake of serum electrolytes necessary for energy production is mediated by a 
person’s resting energy expenditure (REE), which is the rate at which a person expends energy at 
baseline to maintain basic physiologic functioning (Castellini et al., 2014).  The higher the rate of 
REE, the more energy produced and an associated increased need for cellular reuptake of 
electrolytes.  Therefore, it is hypothesized that a diagnosis of anxiety, or impaired psychiatric 
functioning, may also influence the development of RH in individuals with AN. 




Due to the severity of complications associated with RH, many clinicians recommend 
phosphorus supplementation during medical hospitalization for AN (Birmingham, Alothman, & 
Goldner, 1996; Orenstein et al., 2003; Whitelaw et al., 2010).  Currently there is wide variability 
in approaches to phosphorous supplementation during the refeeding phase with some clinicians 
recommending supplementation only when a patient’s serum phosphorous level falls below the 
reference range value for hypophosphatemia of < 2.9 mg/dL, while others supplement 
throughout the refeeding phase and titrate dosage when the serum level approaches accepted 3.0 
mg/dL cutoff (Schwartz, Mansbach, Marion, Katzman, & Forman, 2008; SAHM, 2014).   
Summary 
 The review of literature summarized in this chapter highlights a gap in the knowledge of 
contributing factors that influence the development of RH in AYA with AN.  Although it is 
understood that %mBMI at admission negatively influences serum phosphorus level during 
nutritional rehabilitation, body weight alone does not encompass the entirety of the risk in this 
population.  To best understand the development of this potentially fatal complication of 
nutritional restoration for individuals with AN, analysis which examines multiple co-existing 
















This research study was a retrospective cohort design conducted at Boston Children’s 
Hospital (BCH).  Diagnosis of AN was made by the psychiatry team during admission or follow 
up visits, physician notes, or description of symptoms of AN by report in the psychiatry service 
note using Diagnostic and Statistical Manual of Mental Disorders, 5th edition ([DSM-V]; APA, 
2013) criteria.  Cases were individual charts that reported a serum phosphorous at or below 2.9 
mg/dL during hospitalization.  Controls were those individual charts that reported a serum 
phosphorous level that never dropped below 3.0 mg/dL during hospitalization.  
Setting 
 Participants were individuals admitted to BCH; specifically, unit 7 West adolescent 
medicine service.  This site was chosen for a number of reasons.  First, the investigator has 
access to this patient population through employment status.  Second, BCH is one of the largest 
pediatric hospitals in the United States and hosts the oldest adolescent medicine service in the 
country.  The division of adolescent and young adult medicine sees over 17,000 patients annually 
(BCH, 2016), and provides care to adolescents and young adults to age 24 years diagnosed with 
an eating disorder.  The division of Adolescent/Young Adult Medicine hosts grant funded 
Maternal-Child Health Bureau multi-disciplinary training in adolescent medicine, provides 
instruction in adolescent medicine for Harvard Medical School, and is a leader in adolescent 
medicine related scholarship, research, and service.  Prior to data collection, consultation with 
quality improvement specialists at BCH revealed that 95-97 individuals diagnosed with AN were 
admitted to the target site and unit annually between 2010 and 2014, making this sampling frame 
likely to have an adequate number of individual records available for analysis.  Previous work 
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revealed a rate of 17% hypophosphatemia defined as serum phosphorus < 2.9 mg/dL within the 
population at the target site (Kells et al., unpublished data).  This is consistent with a recent 
systematic review of RH in adolescents that described a range of 0-38% hypophosphatemia in 
adolescents with AN (O’Connor & Nicholls, 2013). 
Study Sample 
The sampling frame included all AYA aged 10-24 years admitted to BCH for treatment 
of AN, consistent with the age range reported in the literature when examining this topic 
(O’Connors & Nicholls, 2013) over a seven-year time period from 2010-2016. This time frame 
started at the most recent complete year that records were available (2016, as study began in 
2017) and went back in years until adequate sample size was met.  Individuals with multiple 
hospitalizations were included in the analysis one time using the most recent admission.   
 Inclusion criteria for medical records to be accepted into the study included age 10-24 
years, male and female, admitted to target unit during sampling time frame, diagnosis of 
anorexia nervosa either binge/purge or restricting subtypes or atypical anorexia nervosa. 
Exclusion criteria included age less than 10 or greater than 24 years, co-morbid diagnosis of 
bulimia nervosa, binge eating disorder, serious mental illness including schizophrenia, 
schizoaffective disorder, medical or psychiatric hospitalization within the last 14 days, feeding 
method other than oral or NG (gastric tube, TPN).  Psychiatric comorbid diseases were included 
as exclusion criteria due to potential influence these diseases may have on nutritional restoration 
and psychiatric scores that are included as variables of interest. 
Research Design 
 Research questions were examined using a retrospective cohort design using existing 
patient medical record data.  Initial list of individuals diagnosed with AN were generated using 
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the Childrens360 electronic medical record system.  This system provides systematic review of 
patient charts to generate data.  The Childrens360 system was coded to generate a list of all 
charts in which a clinician billed for AN at any point, utilized the institutional Clinical Practice 
Guideline (CPG) for restrictive eating disorders, or institutional eating disorder orderset, then 
narrowed search using inclusion and exclusion criteria. The investigator and two research 
assistants (RA) hired from the BCH Institutional Centers for Clinical and Translational Research 
(ICCTR) then reviewed the list generated by Childrens360 for inclusion and exclusion criteria 
prior to data collection. Charts that did not meet criteria were removed, including four 
individuals diagnosed with unspecified feeding/eating disorder, seven Avoidant/Restrictive Food 
Intake Disorder (ARFID), 19 with eating disorder not otherwise specified, and three individuals 
who received NJ feeds.  The initial list generated 350 charts via Childrens360 system during the 
sampling time frame, charts were entered into the study in backwards chronological order 
starting with most recent until sample size of three hundred was met. 
The Childrens360 system mined data from patient charts including age, admit and 
discharge dates, sex, ethnicity, race, weight on admission and daily, height, BMI, daily vital 
signs, and daily laboratory values. The investigator and RAs reviewed Childrens360 data for 
completion and accuracy, and collected all remaining required data from the existing individual 
patient medical records using a medical record abstraction tool developed for the study 
(Appendix A).  Data collected by the investigator or RAs included premorbid weight, percent 
median body weight, Global Assessment of Functioning or Children’s Global Assessment Scale 
score, diagnosis and subtype of anxiety, daily phosphorus dose, and daily formula amount.  
RAs received baseline training in research methods and human subjects protection via 
standard protocol of ICCTR.  Additional study specific training for RAs was conducted by the 
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investigator, including study orientation, patient population description, and standard charting 
specific to diagnosis.  For both RAs, investigator performed quality assurance of complete chart 
review for agreement of the first 5 charts abstracted by RA, the 15th chart (10 charts later), and 
every 25th chart until completion of study.   
Inpatient Protocol 
 All individuals admitted to the BCH Adolescent Medicine service for evaluation and 
management of AN were placed on the restrictive eating disorders CPG. This CPG included 
specific instructions for care including criteria for admission, vital sign and laboratory 
monitoring, activity, non-adherence guidelines, and nutritional rehabilitation.  With regard to 
meals, after meeting with a dietitian to discuss prior intake and habits, parents were required to 
make meal selections for all individuals under the age of 18 years. Patients were weighed daily 
before 7 a.m. after voiding, backward on the scale wearing only a hospital gown and expected to 
gain at least 0.2 kg per day.  Ensure© or Ensure Plus© were given for failure to meet weight gain 
goals.   
Patients were seated in their room for meals, on their bed if vital signs were unstable or in 
a chair if vital signs were within normal limits and remained on bed rest for at least one-hour 
post meal. One trained clinician (registered nurse, clinical assistant, or dietician) was present for 
meal times, in which individuals had 30 minutes to complete all components of the meal. Failure 
to complete all components of the meal in the allotted time resulted in 20 minutes allowance to 
complete oral Ensure© or Ensure Plus© replacement under nursing supervision.  If an individual 
was still unable to complete liquid supplementation orally, a NG tube was placed at the bedside 
and remaining supplementation was given enterally. The NG tube was removed and the patient 
was offered an oral meal tray at the next meal.  
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With regards to supplementation, standard practice was that all patients were started on 
250 mg twice per day of oral phosphorous supplement as well as a multivitamin on admission. 
Phosphorus supplementation dose was increased at clinician discretion for down-trending serum 
level on daily laboratory evaluation or if the level fell below the accepted cutoff of 2.9 mg/dL.  
There were no written protocols in place with regards to phosphorous supplementation.  
Instruments 
 A medical record abstraction tool was developed by the investigator using Research 
Electronic Data Capture (REDCap) software (Appendix A).  The tool included an assigned 
unique identifier and all variables listed in Table 2.   
The Global Assessment of Functioning (GAF) or Children’s Global Assessment Score 
(CGAS) are brief numeric rating scales that measures an individual’s overall level of 
psychological disturbance.  The GAF or CGAS were collected as a measure of psychiatric   
distress for individuals. The GAF was first introduced by the DSM- III (1980) and from that time 
has been the most widely used psychological disability assessment in the United States (Gold, 
2014).  Although the recently released DSM-5 has recommended phasing out the GAF in favor 
of more specific assessments of functioning, the GAF is still used by many (Gold, 2014).  BCH 
utilized the GAF for all individuals prior to August 2012, and continues to use the GAF as a 
measure of psychiatric function for some individuals aged 18 and older or at clinician discretion.  
The GAF has been used for over three decades in myriad of patient populations, in several 
countries, and across the lifespan including children, adults and elderly individuals (Monrad Aas, 
2010).  Additionally, the GAF has been used in research studies investigating inpatient 
populations (Urbanoski, Henderson, & Castel, 2014) as well as adolescent inpatients (Haggerty 
et al., 2015).   
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The GAF is comprised of overall assessments of psychological, social, and occupational 
function (Moos, McCoy, & Moos, 2000).  The 0 to 100-point scale is broken into 10-point 
sections, which have specific associated scoring instructions. Higher scores reflect higher levels 
of psychological functioning; lower scores signify increasing levels of mental illness. Briefly, a 
score of 1-10 indicates persistent danger to self/severe mental illness; 11-20 indicates a danger to 
self/others, failure to maintain hygiene, and impaired communication; 21-30 indicates that 
behavior is influenced by delusions or hallucinations, impaired communication or judgment, and 
an inability to function in almost all areas; 31-40 indicates impaired reality testing, 
communication, as well as major impairments in several areas such as judgment, thinking, and 
mood; 41-50 indicates serious symptoms or any impairment in social, occupational, or school 
functioning; 51-60 indicates moderate symptoms or moderate difficulty in social occupational, or 
school functioning; 61-70 indicates some mild symptoms or some difficulty in functioning but 
generally has meaningful interpersonal relationships; 71-80 indicates transient 
symptoms/reactions to stressors; 81-90 indicates absent or minimal symptoms, and general 
satisfaction with life; 91-100 indicates superior functioning (APA, 2000, p. 34).  A score of 0 
indicates inadequate information (APA, 2000).  
The GAF was adapted by Shaffer et al. in 1983 for use in youth (Shaffer et al., 1983).  
The adapted tool is titled the Children’s Global Assessment Scale (CGAS).  The CGAS is used 
in children, adolescents, and young adults to assess psychiatric functioning as the GAF does in 
adult populations, using the 10-point system with examples in each section described above.  
Studies demonstrated adequate discriminant validity comparing inpatient to outpatient settings as 
well as concurrent validity comparing the CGAS to other measures of psychiatric functioning, 
specifically the Conners Index (Shaffer et al., 1983) and the Child Behavior Checklist (Bird, 
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Canino, Rubiostipec, & Ribera, 1987; Green, Shirk, Hanze, & Wanstrath, 1994) and among 
expert consensus (Hanssen-Bauer et al., 2007). 
In a study comparing “untrained” and “expert” users of the CGAS, the intra-class 
correlation coefficient was reported as 0.73 in “untrained” users, and 0.92 in “expert” users 
(Lundh, Kowalski, Sundberg, Gumpert, & Landen, 2010).  In a recent study at BCH, clinicians 
completed a mandatory training program on the use of the CGAS.  Following this program tool 
accuracy was reported as 80.2%, inter-rater reliability was 0.84 pre-training and 0.95 post-
training (Kahn et al., 2014).   Beginning in August of 2012, all individuals assessed by the 
psychiatry consult liaison team in this study were scored using the CGAS.  Prior to that date, 
individuals were assessed using the GAF. 
Study Variables 
Theoretical and operational definitions of the dependent and independent variables are 
listed in Table 2.  Independent variables were included in the study based on relevant literature 
review outlined in Chapter 2.  The dependent/outcome variable was serum phosphorous level as 
measured in mg/dL.  This variable was measured daily between 9 a.m. and 12 p.m. as per the 
existing unit protocol.  The blood sample was drawn at the bedside by a trained phlebotomist or 
nurse with phlebotomy training and the results are tested and reported by the BCH laboratory. 
Serum phosphorous results were obtained from the “lab” section of the electronic medical 
record. 
The independent variables were located in individual patient medical records.  Weight, 
height, and body mass index (BMI) were obtained from the “measurements” section of the 
medical record. Age and sex were obtained from the “patient profile” section of the medical 
record. Percent median body weight and caloric prescription were obtained from the dietician 
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notes.  Feeding route (oral or nasogastric) were obtained from the nursing documentation 
flowsheet.  Heart rate and blood pressure were obtained from the “vital signs” section of the 
medical record.  Anorexia nervosa subtype, GAF or CGAS score, and diagnosis of anxiety 
disorder were obtained from psychiatry clinical notes.  Serum hemoglobin, potassium, 
magnesium levels were obtained from the “labs” section of the medical record.  
 
Table 2.  
Variables of Interest 
Construct Theoretical Definition Operational Definition 
 Outcome (Dependent) 
Variable 
 
Phosphorous Level Serum phosphorous level 
measured in mg/dL 
Each recorded serum 
phosphorous level during 
hospitalization measured in 
mg/dL in the individual 
patient medical record, 
laboratory view 
 Predictor (Independent) 
Variables 
 
Weight Body weight measured in 
kilograms 
Body weight measured in 
kilograms documented in 
individual medical record the 
morning following admission 
within 1 hour of 0600 as per 
protocol as well as each 
morning within 1 hour of 
0600 
Pre-morbid Weight Body weight in kilograms Self-reported weight prior to 
weight loss as documented at 
any point in the medical 
record 
Age Age in years of life  Age measured in years 
recorded in the individual 
patient record as date of birth 
Sex Sex in male or female Documented sex of patient; 
biologic sex if gender 
transition occurring or 
occurred as documented in 
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the individual patient record 
Body Mass Index (BMI) Weight in kilograms by height 
in meters squared 
Weight in kilograms by 
height in meters square as 
calculated by automated 
formula embedded in 
electronic medical record 
software incorporating 
documented weight and 
height as recorded in patient 
medical record within the first 
24 hours of admission 
Percent Median Body Weight 
(%mBMI) 
Percentage patient body 
weight of the median 
(50%tile) BMI for age and 
height on admission 
Percentage patient body 
weight of median (50%tile) 
BMI calculated using CDC 
standardized growth charts, 
patient age, and patient height 
on admission as recorded in 
the patient medical record 
within the first 24 hours of 
admission 
Heart Rate Heart rate in beats per minute  Documented heart rate in 
beats per minute during 
hospitalization as recorded in 
patient medical record  
Blood Pressure Blood pressure measured in 
mm/Hg 
Documented blood pressure 
in mm/Hg during 
hospitalization as recorded in 
the patient medical record 
Anorexia Nervosa Subtype Defined by American 
Psychological Association as 
Restricting or Binge/Purge 
Subtypes 
Diagnosed APA categorized 
subtype as assessed and 
documented by trained 
mental health clinician in 
patient medical record at any 
point during admission 
Anxiety Disorder Defined by National Institutes 
of Mental Health as: 
Generalized Anxiety Disorder, 
Obsessive Compulsive 
Disorder, Panic Disorder, 
Post-Traumatic Stress 
Disorder, or Social Anxiety 
Disorder 
Diagnosed NIMH categorized 
anxiety disorder as assessed 
and documented by trained 
mental health clinician in 
patient medical record at any 
point during admission   
Global Assessment of 
Functioning (GAF) or Child’s 
Global Assessment Score 
(CGAS) 
GAF or CGAS on admission GAF or CGAS as a measure 
of psychiatric disturbance in 
range 0-100 as assessed and 
documented by trained 
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mental health clinician within 
48 hours of admission 
Hemoglobin Level Serum hemoglobin level 
measured in mg/dL 
Recorded serum hemoglobin 
level measured in mg/dL 
recorded in the patient 
medical record at any point 
during admission 
Potassium Level Serum potassium measured in 
mEq/L  
Recorded serum potassium 
level measured in mEq/L 
recorded in the patient 
medical record at any point 
during admission 
Magnesium Level Serum magnesium measured 
in mmol/L  
Recorded serum magnesium 
level measured in mmol/L 
recorded in the patient 
medical record at any point 
during admission 
Feeding Method Nutritional rehabilitation via 
either oral or nasogastric route 
Feeding route as either oral, 
nasogastric, or both as 
documented in the nursing 
care flowsheet in the patient 
medical record at any point 
during admission 
Caloric Prescription Intended calories consumed 
per day 
Calories prescribed per day in 
kcal as documented by 
trained dietician in patient 
medical record  
Phosphorus Supplementation 
Dose 
Oral dose of supplemental 
phosphorus 
Daily dose of oral phosphorus 
given as documented in the 
medication administration 
record (MAR) section of the 
patient medical record 
 
Data Analysis Plan 
Statistical analyses were completed using SPSS version 25  software.  Summary 
descriptive statistics were used to describe the sample and all variables. For both research 
questions, relationships between independent variables and the dependent variable were 
examined using logistic regression, chi-square analyses, and one-way ANOVA. Relationships 
were considered significant if they reached a p value of less than or equal to 0.05.   
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Testing of assumptions and regression diagnostics were performed. The data was 
examined for outliers and normal distribution of the dependent variable. Scatterplots were used 
to examine relationships for linearity between each variable. Correlations between variables were 
examined using Pearson correlations and tolerance, highly inter-correlated variables were 
reconsidered prior to entry into model. Distribution was evaluated using histograms of 
standardized residuals looking for normality of distribution and normal probability plots. 
Homoscedasticity was evaluated by plotting error variance and examination of residual plot.  
Standardized predicted values were plotted by standardized residuals to examine for errors 
correlated with independent variables.  
Using the definition of hypophosphatemia as a serum phosphorus level of < 2.9 mg/dL 
(Haglin, 2001; O’Connor & Nicholls, 2013), multiple logistic regression was used to identify 
factors associated with the outcome (Question 1).   All variables were entered simultaneously 
using the enter method.  Multivariate regression was used used to examine the relationship 
between the independent variables and the dependent variable of nadir serum phosphorus level 
(Question 2). The multivariate regression was conducted using backward selection.  In this 
method, all variables which meet criteria detailed in bivariate analyses were entered 
simultaneously and removed by a p value criterion of > .10.  
Initial Statistical Data Management 
 All data was collected per above procedures and initially entered into REDCap database.  
Database was then uploaded into IBM SPSS version 25 for statistical management.  Data was 
examined, missing variables were subject to repeat chart review for thoroughness, and variables 
were recoded where applicable as described below.  Phosphorus dose recorded in mmoL was 
converted to mg using calculation of 250 mg=8 mmoL.  Premorbid weight was calculated by 
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adding reported weight loss prior to admission to admission weight.  Where weight loss was 
reported as a range (for example, 20-25 pounds), the average of the range was used.  A number 
of charts reported actual premorbid weight from previous medical records (primary care records, 
previous admissions for other diagnoses).   
 Daily data logs were synthesized into single variables to include in model building.  
Minimum phosphorus level was calculated from daily phosphorus levels to represent phosphorus 
nadir, and then recoded into new variable of 0=no hypophosphatemia (nadir never reached < 2.9 
mg/dL) or 1=hypophosphatemia (nadir reached level of <2.9 mg/dL). Weight gain during 
admission was calculated by subtracting admission weight from discharge weight.  To determine 
if a participant ever received NG feeding, daily feeding method was recoded as 1=oral feeding, 
2=neither/no feeding method recorded, 3=NG feeding, 4=both oral and NG feeding.  A new 
variable was then created in which anything greater than or equal to 3 was recoded to 1=yes 
(received NG feeding), 0=no (never received NG feeding).  Potassium, magnesium, and 
hemoglobin nadirs were coded using minimum recorded daily laboratory values.  Daytime 
bradycardia was coded as 1=yes, 0=no if any recoded heart rate value was less than 50 beats per 
minute between 6 a.m. and 10 p.m.  Nighttime bradycardia was coded as 1=yes, 0=no if any 
recorded heart rate value was less than 50 beats per minute between 10 p.m. and 6 a.m.  
Hypotension was defined as any recording less than 90/50 mmHg.  Orthostasis was defined as 
any recording in which the difference in BP was greater than or equal to 20 mmHg from supine 
to standing or greater than or equal to 40 beats per minute from supine to standing in accordance 
with institutional protocol.  Total formula in Ensure and Ensure Plus  in milliliters was 
calculated by adding all daily values, total calories of formula was calculated by multiplying 
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total milliliters by calories per mL per manufacturer label.  Total phosphorus dose was calculated 
by adding all daily recorded phosphorus supplement doses.   
Protection of Human Subjects 
Institutional Review Board (IRB) approval was sought through BCH and Boston College 
(BC).   Initial IRB approval was granted at BCH and then reciprocal agreement was obtained at 
BC.  All records were de-identified to maintain confidentiality, each chart was assigned a unique 
identifier number as it was entered into the study. There were no hard copies of data abstraction 
tool, electronic records were maintained via REDCAP.  Excel file linking medical record 
numbers to unique identifier numbers were accessible to the investigator solely. The computer 
used for data analysis was password protected.  SPSS files were kept on BC server and not stored 
on investigators personal computer.  Data will be maintained for a maximum of 5 years after 
















 The details of the data analysis and results are presented in this chapter.  Specifically, the 
description of the sample and results of two research questions are addressed.  The two research 
questions were: (1) Which factors best differentiate AYA with AN who develop RH from those 
who do not? and (2) Do the demographic, feeding, and biochemical variables of interest 
influence serum phosphorus level in AYA with AN? 
Sample Description and Demographics 
Three hundred inpatient charts spanning the dates of 9/2010-12/2016 were included in the 
analysis.  The mean age at time of admission was 15.5 years (SD=2.5, range 10.1-22.7 years), 
with a majority of patients representing the adolescent range of 10-19 years (n=288, 96%), and a 
small sample of young adults aged 20 and older (n=12, 4%).  The cohort was primarily female 
(n=265, 88.3%), and white/Caucasian (88.3%).  See Table 3 for additional summary of patient 
characteristics. 
The mean length of stay was 7.36 days (SD=5.9).  Greater than half (53.3%) of the 
population were admitted for less than or equal to 6.9 days. A large portion of the sample was 
diagnosed with AN-R (85%), with smaller groups representing AN-B/P (11.7%), Atypical AN 
(2.0%), and 1.3% were not subtyped in clinical documentation by psychiatry team.  The mean 
baseline weight on admission was 42.8 kg (SD=9.6). Two hundred and ninety-six charts had 
admission baseline weight and height available for BMI calculation.  The mean admit BMI on 
admission was 16.3 (SD=2.6) and average percent median body weight on admission (%mBMI) 
was 82% (SD=12.1). 
 
Table 3.   
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     Child (<10 yrs) 
     Adolescent (10-19 yrs) 









     Female 








    Asian 
    Black/African American 
    Other 
    White/Caucasian 














    Hispanic or Latino 
    Not Hispanic or Latino 










Prior to disease onset, mean weight was 54.2 kg (SD=15.3), and individuals had lost an average 
of 11.3 kg (SD=9.7) before admission.  During hospitalization, average weight gain was 1.8 kg 
(SD=1.5).  Initial caloric prescription varied with a mean of 1714 kcal (SD=324.2).   
 Level of psychiatric functioning was obtained on admission and patients were screened 
using either the Global Assessment of Functioning (GAF) or the Children’s Global Assessment 
Scale (CGAS).  Two hundred and thirty individuals were scored using CGAS score, 59 with 
GAF score, and 11 with neither score. As the tools are scored on the same scale (0-100 points) 
and measure the same variable, they are reported here together. The average CGAS or GAF 
score on admission was 39.1 (SD=11.6, range 5-75).  With regards to co-morbid psychiatric 
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diagnoses, greater than 40% (41.7) of individuals were diagnosed with an anxiety disorder by the 
psychiatry consult team.  Of those, 38% were classified as generalized anxiety disorder, 0.8% 
panic disorder, 0.8% post-traumatic stress disorder, 1.6% social anxiety disorder, 54% “Other” 
(unspecified anxiety disorder, adjustment disorder with mixed anxiety, anxiety disorder not 
otherwise specified), and 4% missing. See Table 3 for further summary of clinical 
characteristics. 
Table 4.   
Descriptive Characteristics of Sample 
 N % 
Anorexia Nervosa Subtype 
   Restricting 
   Binge/Purge 
   Atypical 











Anxiety Disorder Diagnosis 126 41.7 
Anxiety Disorder Subtype 
   Generalized Anxiety Disorder 
   Panic Disorder 
   Post-Traumatic Stress Disorder 
   Social Anxiety Disorder 
   Other 















 M (SD) Range 
Length of Stay 7.4 (5.9) 1-71 
Admission 
    Baseline Weight (kg) 
    BMI (kg/m2) 










    Weight (kg) 







Weight Gain During Admission (kg) 1.8 (1.5) -5.3-7 
Initial Caloric Prescription (Kcal) 1714 (324.2) 1000-3000 
CGAS or GAF Score  39.1 (11.6) 5-75 
Phosphorous Nadir (mg/dL) 3.2 (0.6) 1.5-5.0 
Day of hypophosphatemia 3.9 (3.4) 1-23 
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Eighty-six (28.7%) charts reported a phosphorus level of less than 3.0 mg/dL at some 
point during admission, making the rate of hypophosphatemia in this sample 28.7%.  Mean day 
of hospitalization of first instance of hypophosphatemia was 3.9 (SD=3.4).  The mean 
phosphorus nadir was 3.2 mg/dL (SD=0.6). 
Factors Associated with Refeeding Hypophosphatemia (Question 1) 
Prior to model building, the relationships between the independent variables and the 
dependent variable hypophosphatemia were examined using logistic regression and chi-square 
analyses (Table 5). Variables that were significantly associated with hypophosphatemia during 
admission and considered for the model included ever receiving nasogastric feeding (p=.052), 
%mBMI (p=.019), weight loss prior to admit (p=.043), age (p=.001), weight gain during 
admission (p<.001), potassium nadir (p<.001), magnesium nadir (p=.001), total formula in mL 
(p=.026), total formula in kcal (p=.032).  Total dose of phosphorus was also significant (p<.001), 
but this was not included in the model because the variable measured total dose of phosphorus 
throughout hospitalization.  Therefore, if a participant demonstrated hypophosphatemia, their 
supplemental dose of oral phosphorus would have been increased, making it likely that higher 
total doses of supplement would be associated with lower levels of serum phosphorus.   
Correlations between variables considered for the model were examined using Pearson 
correlation matrix (see Table 6). Several associations were significant at the level of 0.01 or 0.05. 
Correlation coefficients were determined to be highly inter-correlated if r > 0.70.  The 
relationship between total formula in mL and total formula in Kcal was highly inter-correlated, 
with r=.99723.  Considering the greater clinical significance of total Kcal, the total formula in 
milliliters was removed from final model building and total formula in Kcal was retained.   The 
remainder of relationships were not highly correlated; and therefore, retained in the analysis. 




Table 5.   









%mBMI -.027 .019 
Weight Loss Prior to Admit .028 .043 
Age at admission .181 .001 
Weight Gain  .409 <.001 
Potassium Nadir -1.876 <.001 
Magnesium Nadir -2.953 .001 
Total Formula in mL .000 .026 
Total Formula in Kcal .000 .032 
Total Phosphorus Dose .000 <.001 
 
 A logistic regression was performed to ascertain the effects of receiving NG feeding, 
admit %mBMI, weight loss prior to admit, age, weight gain during admission, potassium nadir, 
magnesium nadir, and formula in kcal on the likelihood of hypophosphatemia. Linearity of the 
continuous variables with respect to the logit of the dependent variable was assessed via the Box-
Tidwell (1962) procedure. A Bonferroni correction was applied using seven factors in the model 
resulting in statistical significance accepted at p<0.003125.  Using this significance level, all 
continuous independent variables were linearly related to the logit of the dependent variable and 
therefore included in the analysis.  Five cases of studentized residuals greater than 2.5 standard  
 
Table 6.   
Pearson Correlations for Continuous Variables in Logistic Regression 
 



























%mBMI 1        
Weight Gain 
During Admit 
-.350** 1       
Weight Loss 
During Admit 
.078 -.002 1      
Potassium 
Nadir 
.137* -.192** -.014 1     
Magnesium 
Nadir 
-.008 -.046 -.163 .224 1    
Total Formula, 
mL 
-.067 .334** .025 -.159** -.071 1   
Total Formula, 
Kcal 
-.063 .323** .022 -.149** -.076 .997** 1  
Age at Admit -.135* .007 .264** -.162** -.250** -.047 -.057 1 
 
** significant at level of 0.01 (2-tailed) 
*   significant at level of 0.05 (2-tailed) 
 
deviations were revealed, all of which were kept in the analysis.   
The logistic regression model was significant (x2=59.3, p<0.001), and accounted for 
21.9% (Cox & Snell R2) to 31.0% (Nagelkerke R2) of the variance, rejecting the null hypothesis 
that there is no association between factors identified in AYA with AN who develop RH and 
those who do not.  Hosmer and Lemeshow test was not statistically significant (p=.445), 
indicating the data was a good fit to the model. A total of 76.7% of the cases of 
hypophosphatemia were correctly classified. 
Of the independent variables, NG feeding (p=.054), age at admission (.022), weight 
gained during hospitalization (p=.003), potassium nadir (p=.001), and magnesium nadir (p=.024) 
contributed significantly to the model.  Percent median body on admission, weight loss prior to 
admission, total formula in Kcal did not.  Individuals who received NG feeding were 
found to have 3 times higher odds of hypophosphatemia.  Increasing age was associated with 1.2 
times higher likelihood, every kilogram of weight gain during hospitalization was associated 
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with 1.5 times higher odds.  Alternatively, for each unit reduction in potassium, the odds of 
hypophosphatemia increased by 9.2 and for each unit reduction in magnesium, the odds were 
13.7 higher. 
 The regression model was performed two additional times.  First excluding the outliers 
(those with studentized residuals greater than 2.5), and second excluding all individuals 
diagnosed with atypical anorexia nervosa (n=6).  Like the model described above, NG feeding, 
%mBMI, weight loss prior to admission, age at admission, weight gain during hospitalization, 
potassium nadir, magnesium nadir, and total formula in both mL and kcal were associated with 
the outcome variable of hypophosphatemia.  Excluding outliers, the final model included NG 
feeding (p=.056), age at admission (p=.016), weight gain during hospitalization (p=.002), 
potassium nadir (p=.002) and magnesium nadir (p=.022).  The odds ratios remained the same as 
described above.  Excluding individuals diagnosed with atypical anorexia, again the same 
variables were included in the final model, NG feeding (p=.023), age at admission (p=.011), 
weight gain during hospitalization (p=.005), potassium nadir (p<.001), and magnesium nadir 
(p=.050).  Odds ratios remained the same as initial model.  Thus, these two additional analyses 
did not reveal any new results.  
 To determine if there were statistically significant differences between those who 
received NG feeding and those who did not, chi-square analysis, t-tests, and logistic regression 
were performed.  The two groups were not statistically significantly different at baseline 
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Table 7.  
Logistic Regression Predicting Likelihood of Hypophosphatemia Using All Factors Associated 
with the Outcome 
 
 B SE Wald df p Odds 
Ratio 
95% CI 
NG Feed Ever 1.078 .559 3.713 1 .054 2.937 .982-8.789 
%mBMI -.003 .015 .031 1 .861 .997 .968-1.028 
Weight Loss 
Prior to Admit 
.011 .018 .361 1 .548 1.011 .975-1.048 
Age at Admit .169 .074 .5.245 1 .022 1.184 1.025-1.368 
Weight Gain 
During Admit 
.427 .142 8.985 1 .003 1.533 1.159-2.2026 
Potassium 
Nadir 
-2.222 .671 10.958 1 .001 9.259 2.475-34.482 
Magnesium 
Nadir 




.000 .000 .210 1 .647 1.000 .999-1.001 
Constant 8.968 
 
admission. Additionally, when considering factors significantly associated with 
hypophosphatemia, the two groups did not differ on weight gain during admission, potassium 
nadir, or magnesium nadir. However, the groups did have significant difference in starting 
caloric prescription, with those who received NG feeding receiving significantly more calories at 
the start of the admission and total calories of formula given with those who required NG feeding 
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Table 8.   
Group differences Between Those Who Received NG Feeding vs. Those Who Did Not 
 




p Odds Ratio 
Sex (female)   .852 .853 
Age (years) 15.5 (2.4) 15.2 (2.8) .444 .880 
BMI (kg/m2) 16.3 (2.6) 16.4 (2.9) .784 1.191 
%mBMI 81.9 (11.9) 83.3 (12.9) .488 .989 
Premorbid Weight 
(kg) 
54.3 (13.9) 53.7 (23.3) .855 .941 
Weight Loss Prior to 
Admit  (kg) 
10.4 (8.7) 11.5 (16.1) .551 1.106 
Starting Kcal  1696.8 (311.3) 1817.1 (379.1) .023* 1.002 
Weight Gain During 
Admit (kg) 
1.7 (1.42) 2.1 (1.76) .091 .775 
Potassium Nadir  3.7 (.31) 3.6 (.43) .070 .778 
Magnesium Nadir 2.0 (.15) 1.9 (.15) .267 .509 
Total Formula 
Received in Kcal 
1554 (2553) 11210 (17437) <.001* 1.000 
 
Factors Associated with Phosphorus Nadir (Question 2) 
Similar to Question 1, relationships between independent variable and the dependent 
variable serum phosphorus level were examined.  Continuous independent variables were 
assessed using logistic regression, categorical independent variables were assessed using chi 
square to determine relationship with phosphorus nadir. Relationships were considered 
significant if they reached a p value of less than or equal to 0.05. Variables that were 
significantly associated with phosphorus nadir were bradycardia at night (p=.047), admit BMI 
(p=.030), overnight heart rate minimum (p=.025), magnesium nadir (p=.002), formula amount in 
kcal (p=.037) and anxiety disorder diagnosis subtype (p=.002).  Also significant was total dose 
of phosphorus during admission (p<.001); however, this was not included in the model because 
it does not provide clinically pertinent information.  
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A multiple regression was used to test if the factors listed in Table 9 significantly 
predicted minimum serum phosphorus level.  Partial regression plots and plot of studentized 
residuals against predicted values were examined to determine linearity.  Durbin-Watson statistic 
was 2.135 indicating no meaningful serial correlation and independence of residuals.  Visual  
inspection of studentized residuals versus unstandardized predicted values showed 
homoscedasticity. Multicollinearity diagnostics were examined using VIF and Tolerance, both 
values approached 1.0 in final model making multicollinearity among final model variables of 
less concern. One case showed a studentized deleted residual of -3.099, however there were no 
concerning leverage values (greater than 0.2) and no Cook’s Distance greater than 1.0; therefore, 
all cases were kept in final analysis. Normality was assessed via Q-Q plot of studentized 
residuals.  
Final model included admit BMI and magnesium nadir.  The model was statistically 
significant F (2,122) =11.986, p<.001, R2=.168, meaning that 16.8% of the variance in 
phosphorus nadir is explained by the factors listed above, adjusted R2=.158. Magnesium nadir 
contributed most to the model with b=.324 (p<.001), indicating for every 1-unit increase in 
magnesium results in 1.213 increase in phosphorus, followed BMI b=.271 (p=.002) with each 
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Table 9.  
Variables Significantly Associated with Phosphorus Nadir   
 
 x2 p 
Bradycardia at night 45.3 .047 
Anxiety Disorder Subtype 281.1 .002 
 F p 
BMI 32.7 .030 
Overnight heart rate nadir 1.5 .025 
Magnesium Nadir 3.0 .002 
Formula Amount in Kcal 1.4 .037 
Total Dose of Phosphorus  4.2 <.001 
 
Table 10. 
   
Summary of multiple regression analysis 
 
 B SEB  
Intercept -.135 .695  
BMI .060 .019 .271* 
Magnesium Nadir 1.213 .314 .324* 
*p<.05 
B= unstandardized regression coefficient; SEB= standard error of the coefficient;  




This study sought to address two questions, specifically, what factors were associated 
with the outcome of hypophosphatemia and what factors were associated with a change in serum 
phosphorus level, regardless of whether that level went below the threshold for 
hypophosphatemia. A logistic regression was performed to address the first question.  The 
findings suggest that individuals who received NG feeding, were older, gained more weight, and 
had other electrolyte abnormalities were at the greatest risk for developing hypophosphatemia.  
Multivariate regression analyses were used to determine what factors influence serum 
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phosphorus level.  This analysis suggested that lower weight on admission and other electrolyte 
abnormalities contributed variation to serum phosphorus level; however, the amount of variance 


























The purpose of this study was to identify factors that contribute to the outcome of RH in 
a population of AYA admitted the hospital with AN.  This study builds on prior knowledge of 
risk of RH described in the literature, and contributes unique knowledge of this outcome in the 
AYA population.  This chapter reviews and discusses the results of this study, the limitations, 
and implications for nursing practice, education, research and policy. 
Discussion 
 The sample was primarily female, white/Caucasian, and non-Hispanic, consistent with 
literature describing prevalence of AN in the population (Hoek & van Hoeken, 2003; Smink et 
al., 2012).  The majority of the sample was adolescent, between the ages of 10-19 years with a 
mean age of 15.5.  This coincides with the peak onset of AN (Swanson et al., 2011).  AN-R, was 
reported as the most common subtype in this sample.  Individuals had a compromised level of 
psychiatric functioning as measured by CGAS or GAF score, and a large portion of the sample 
had diagnosed anxiety disorder, similar to other studies that report high rates of comorbid 
anxiety in this population (Hudson et al., 2007; Swanson et al., 2011). 
 The logistic regression model to predict factors that are associated with RH in AYA 
included NG feeding, age at admission, weight gain during hospitalization, potassium and 
magnesium nadir. It is of clinical relevance that in this sample, NG feeding was associated with 
three times higher odds of RH. The meal-based protocol utilized in this population indicated that 
NG feeding was only provided in cases of food refusal or failure to complete meals. There is not 
a clear consensus in the literature on whether NG feeding itself or method of NG feeding as 
continuous or bolus nutrition is predictive of or protective against RH.  Systematic and 
HYPOPHOSPHATEMIA IN AN   
 
51 
integrative reviews have found between 1-35% incidence of RH among individuals diagnosed 
with AN and fed via NG (Rizzo et al., 2018; Kells et al., 2016).   
In this sample, differences between groups of those who received NG feeding and those 
who did not revealed that those who received NG feedings had a higher initial caloric 
prescription.  This questions whether high starting calorie requirement was in some part related 
to the necessity of NG feeding due to patient inability to complete the volume of meals.  It is also 
unclear if those who received NG feeding had a greater degree of starvation resulting in RH 
during admission.  However, in comparing the two groups, those who received NG feeding did 
not have lower weight during admission, percent median body weight, BMI, or weight loss prior 
to admission, which argues against this supposition. 
Traditionally, a lower caloric diet during hospitalization has been suggested to prevent 
RH and refeeding syndrome.  However, higher caloric prescription at admission has been 
recommended to expedite weight gain and promote shorter duration of hospitalization (Garber et 
al., 2012), and has not been associated with poor outcomes (Garber et al., 2016; Garber et al., 
2012; Whitelaw et al., 2010).  Starting caloric prescription was not significantly associated with 
either hypophosphatemia or phosphorus nadir in this study.  As the medical complications of AN 
are related to starvation as a result of the psychiatric profile of the disease, and treatment is 
focused on psychiatric care, the inpatient medical setting may not be of greatest utility for these 
individuals.  Improving inpatient medical care to facilitate timelier discharge to needed 
psychiatric care would be of great clinical significance.  The findings of this study would support 
higher caloric prescription on admission to promote reduced length of stay and transfer to 
appropriate psychiatric care. 
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 For every year of age, likelihood of RH increased in this sample.  The results show a 1.2 
times higher likelihood of RH in older individuals.  Previous studies have described poorer 
outcomes for individuals with older onset or age at initial assessment for AN (Ackard et al., 
2014; Buhren et al., 2013; Wentz et al., 2012).  Additionally, a longitudinal study reported that 
younger individuals had lower mortality rates supporting the theory of worse outcomes for older 
AYA with AN (Franko et al., 2013).  Considering the peak incidence of AN occurs between 15-
19 years of age (Wentz et al., 2012; Favaro et al., 2009), older age at assessment or treatment 
may be related to longer duration of illness (Franko et al., 2013).  Identifying the difference 
between age as a predictor of RH versus longer duration of illness was not ascertained in this 
study.  Future studies should include an assessment of illness duration in regards to incidence of 
RH.   
The finding of older age on admission as a predictor of poorer outcomes in this study, in 
addition to previous studies reporting less favorable results for older individuals with AN 
(Ackard et al., 2014; Buhren et al., 2013; Wentz et al., 2012), underlines the demand to advance 
public health efforts to improve awareness and screening.  Recent literature has identified 
primary care clinician discomfort, perceived lack of confidence, and lack of resources in the 
diagnosis and management of eating disorders in adolescents (Higgins & Cahn, 2018; Robinson, 
Boachie, & Lafrance, 2013).  Improved primary care physician screening and referral to 
treatment earlier in disease trajectory and when individuals are younger could be of benefit in the 
prevention of RH.   
 Weight restoration is a primary goal of medical hospitalization for individuals with AN 
(AAP, 2003; ADA, 2001; APA, 2006; Golden et al., 2003).  In this sample, every kilogram of 
weight gained during hospitalization was associated with 1.5 times higher odds of developing 
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hypophosphatemia.  This finding may be reflective of low weight on admission, given research 
that suggests that low BMI on admission was predictive of RH (O’Connor & Nicholls, 2013) in 
that those with lower weight on admission have more weight to gain during the refeeding 
process. This study did not examine the rate of weight gain; however, previous reports have 
found that rate of weight gain was not predictive of RH (Redgrave et al., 2015).  Further 
investigation of the rate of weight gain among this population may be warranted.  
 The results suggest that low levels of serum potassium and magnesium predicted low 
serum phosphorus. This finding is consistent with literature that highlights the importance of 
electrolyte imbalances during refeeding syndrome (Brown et al., 2015; Fuentebella & Kerner, 
2009; Kraft et al., 2005; Rio et al., 2012).  This study revealed elevated odds ratios, and 
therefore, increased risks of RH in those participants who demonstrated hypokalemia as well as 
those with hypomagnesemia. There may be clinical value to further elucidate temporal 
relationships and nadir levels of potassium and magnesium to better predict and prevent RH in 
this population.  
 This study reported that scores on psychiatric functioning scales (GAF and CGAS) and 
diagnosis of anxiety were not significantly associated with RH.  Although anxiety disorder 
subtype was significantly associated with nadir phosphorus level, it was not in the final model as 
a predictor of the outcome.  Previous reports have outlined that higher anxiety levels were 
associated with higher rates of resting energy expenditure (REE) (Van Wymelbeke et al., 2004; 
Castellini et al., 2014).  In this study, it was posited that higher levels of anxiety would result in 
lower serum phosphorus levels as mediated by higher resting energy expenditure.  However, 
direct measurement of REE through indirect or direct calorimetry and measurement of anxiety 
level utilizing validated tools (such as the Hamilton Anxiety Rating Scale, Beck Anxiety 
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Inventory or others) were not obtained.  These measurements should be considered in future 
prospective studies.   
Multivariate analyses conducted revealed that BMI on admission and magnesium nadir 
levels contributed to variance in serum phosphorus levels, independent of the outcome of 
hypophosphatemia.  Variance in serum phosphorus levels, without reaching the threshold of 
hypophosphatemia, may be clinically significant as clinicians may use dropping serum 
phosphorus levels to guide interventions such as dose of supplementation or use of prophylactic 
supplementation.  The two predictors of variance in serum phosphorus have been reported in 
earlier studies.  Low BMI on admission has been previously cited in the literature as a predictor 
RH in individuals with AN (O’Connor & Nicholls, 2013; Ornstein et al., 2003).  Additionally, 
electrolyte abnormalities have been reported to occur concurrently with RH in refeeding 
syndrome (Fuentebella & Kerner, 2009; Kraft et al., 2005; Rio et al., 2012).   
 The development of RH appears to be multifactorial.  Clinical scoring tools that consider 
multiple predictors of an outcome have been useful in a number of medical settings, including 
determination of acute appendicitis (Wagner, Tubre, & Asensio, 2018), predicting risk of cancer 
among hepatitis B carriers (Wong et al., 2010), and many others.  Future research directed 
towards further identification of predictors and models that can accurately predict RH would be 
of great clinical utility.  Research that could better predict RH may inform development of a 
clinical scoring tool similar to those found in other settings.  Such clinical scoring tools for use in 
this population may guide clinicians with regards to caloric prescription, phosphorus 
supplementation, electrolyte monitoring, and risk stratification during inpatient care. 
 
 




This study is not without limitations, and findings presented should be interpreted with 
caution.  First, retrospective studies are limited by the availability and existing documentation of 
variables.  In this study, retrospective chart review was dependent on nursing, dietician, 
physician, and psychologist documentation that was variable, provider dependent, and 
sometimes incomplete.  Documentation especially varied in free written progress notes by 
physicians, dieticians, and psychologists.  For example, pre-morbid weight was at times reported 
in absolute terms, with regards to weight loss compared to previous weight, or not documented at 
all.   
Variable selection was limited to that which was existing in the medical chart.  Anxiety 
diagnosis and either GAF or CGAS score were used to explore the relationship between 
psychiatric distress and the outcome of hypophosphatemia; however, resting energy expenditure 
and anxiety level specific scoring were not available in this retrospective review.  
Provider specific methods and reporting made identifying and classifying variables 
challenging.  For example, in the case of anxiety disorder diagnosis, Anxiety Disorder NOS and 
Unspecified Anxiety Disorder were used in an interchangeable way across clinicians; however, it 
is unclear if these two categories capture the same target diagnosis.  Intrinsic to the seven-year 
date range utilized in this study is variations in clinical practice, which influenced both 
documentation and procedures.  This was seen with the use of the CGAS versus the GAF scoring 
tool to measure psychiatric functioning.  In this timeframe, the GAF was used for all individuals 
prior to August 2012, after which time the CGAS was used by the psychiatry consultation team.  
Additionally, classification of AN was redefined with the release of the DSM-V in 2013.  
Subsequently, AN subtype and identification of AN cases may reflect these changes in persons 
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admitted prior to 2013 and those admitted after publication date.  The two changes to the 
definition of AN between DSM-IV and DSM-V includes the removal of amenorrhea and the 
criteria of being less than 85% of ideal body weight.  Therefore, an individual diagnosed prior to 
the DSM-V release may have been classified as Eating Disorder Not Otherwise Specified (ED-
NOS), while an individual with a similar profile diagnosed after 2013 may have been classified 
as AN.  
 The individuals included in this study may not be representative of all AYA diagnosed 
with AN.  Although the primarily female, non-Hispanic white sample was congruent with 
literature reporting prevalence rates of AN, males and minority populations were 
underrepresented. There were no available data related to sexual or gender orientation.  Gender 
dysphoria is an emerging topic within the field of eating disorders, with case reports of co-
occurrence of the two reported (Ewan, Middleman, & Feldman, 2014; Hepp & Milos, 2002; 
Murray, Boon, & Toyz, 2013; Strandjord, Ng, & Rome, 2015), and increased interest in the 
complexities of treating individuals within that population.  It remains unclear if gender identity 
influences severity of AN and, in turn, medical complications such as RH.  Additionally, the 
setting was a single site in the northeastern part of the United States, which utilized a site-
specific protocol for nutritional rehabilitation. Alternative feeding regimens, phosphorus 
supplementation, laboratory monitoring, psychiatric care plans and other aspects of inpatient 
medical hospitalization were not explored or compared in this current study.  
Implications for Nursing Practice 
This study incorporates the nursing paradigmatic perspectives of person and health and is 
consistent with nursing themes of inquiry of life processes for optimal human functioning 
described by Donaldson and Crowley (1978).  This inquiry generated new knowledge on the 
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relationship between factors that are associated with development of serum hypophosphatemia or 
variation in serum phosphorus level for AYA with AN.  The findings may be used to identify 
risk and to inform interventions that include individualized care plans for individuals for 
prevention and management of RH, including appropriate phosphorous supplementation and 
nutritional protocols.  As advocates for optimal patient care and key members of the clinical care 
team, nurses are uniquely situated to develop and implement such individualized care plans.  
Improved prevention and management of RH during medical admission may facilitate timelier 
transfer to needed psychiatric care for this population.  Working to positively influence the 
health of individuals, group, and society is in accordance with the nursing’s social contract 
(American Nurses Association [ANA], 2010) to provide the common “good” of health care 
within a diverse and global society.   
Implications for Nursing Education 
This study provides insight into the complex nature of treatment for AYA with AN, with 
nutritional, nursing, medical, and psychiatric care components.  This highlights the need for 
interdisciplinary care team involvement.  Nursing education that emphasizes understanding of 
complex physiologic systems and collaborative team-based approaches is imperative.  Nursing 
education on the general aspects of care of individuals with AN is also of concern and must be 
addressed.  Research suggests that improved understanding of care for individuals with AN and 
development of therapeutic relationship is challenging for nurses (Ramjan, 2004; Salzmann-
Erikson & Dahlen, 2017) and that patients may respond more favorably to treatment approaches 
with improved nursing relationships (Salzmann-Erikson & Dahlen, 2017).  Education on the 
complexities of treatment of AN may enable greater rapport between nurse and patient, resulting 
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in more advantageous patient outcomes and nurse satisfaction in working with this challenging 
population. 
Dissemination of research findings in settings that incorporate these key components of 
education should be pursued.  Interdisciplinary and nursing focused clinical conferences, peer-
reviewed journals, and development of AN focused curriculum would promote improved 
clinician understanding of care for this population and incorporate findings into clinical practice.  
Implications for Nursing Policy 
Given the complex bio-psycho-social nature of AN (SAHM, 2015), interdisciplinary 
collaboration with colleagues in the fields of psychiatry, nutrition, and medicine will be 
important to continue to improve care for AYA with AN.  The Institute of Medicine (IOM) 
published a report envisioning the future of nursing (2010).  In this report, the second 
recommendation is to “expand opportunities for nurses to lead and diffuse collaborative 
improvement efforts” (IOM, 2010, p. 11).  Adolescent health, and in particular eating disorders 
in adolescence, requires collaborative efforts to solve the complex, multifaceted questions 
associated with healthcare for this population.  Identification of risk factors associated with RH 
during nutritional restoration is one area in which interdisciplinary collaboration is imperative.  
This study begins to describe some potential considerations for identification of risk and 
prevention of RH and may be used to develop future policy to standardize and improve the care 
for AYA with AN.  
Recommendations for Future Research 
The ultimate goal of the nursing discipline is to enhance the health of individuals and 
society (ANA, 2010), and in conducting collaborative, interdisciplinary, multiple methods 
research healthcare scholars can elucidate knowledge for evidence-based practice (Woods & 
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Magyary, 2010).  The overall results of this study provide information regarding the risk of RH; 
however, they do not fully capture the risk in this population. Together, predictors in the 
multivariate analyses accounted for only 16% of the variance in phosphorus nadir during medical 
admission in this population.  This relatively low percentage of explained variance highlights the 
need for further investigation. 
Other factors of RH should be explored to further identify risk, guide clinical practice, 
and improve patient care.  Specifically, pH of body fluids was found to influence 
hypophosphatemia in individuals diagnosed with alcoholism (Gutierrez, 2017) and could be 
explored in AYA with AN.  Physiologic functions that influence phosphorus absorption and 
excretion are of interest.  Vitamin D has shown to play a role in the absorption of phosphorus in 
the gut (Boyle & Goldfarb, 2017; Hruska, 2017); therefore, serum vitamin D levels or vitamin D 
supplementation could be investigated in relationship to RH.  PTH levels are known to influence 
phosphorus reabsorption in the renal tubules (Hruska, 2017), and could be included in future 
exploration of RH risk factors.   
Illness trajectory is of interest with relation to RH, as Whitelaw et al. (2010) found that 
fewer admissions were associated with higher likelihood of RH.   This is suggestive that RH is at 
higher risk earlier in the course of the disease, making early identification and intervention of an 
important consideration.  Furthermore, AN is a chronic disease, with less than half of patients 
achieving full recovery, and up to 20% of individuals experiencing chronic AN (Steinhausen, 
2009). As such, early versus later risk factors may influence management of the illness over 
time.   
While there is some literature describing the experience of nasogastric tube feeding for 
individuals diagnosed with AN (Halse et al., 2005), little is known about the experience and 
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meaning of nutritional restoration during hospitalization for this population.  A mixed method 
study could be designed to further explore this phenomenon and the mind-body relationship 
between NG feeding meaning, anxiety or psychiatric distress, and serum phosphorus levels as 
mediated by resting energy expenditure.  
Further inquiry into the intersection of nutritional status on admission and starting caloric 
prescription may be of interest.  In the population reported in this research, starting caloric 
prescription was at dietician discretion and based on intake prior to admission. One could 
consider a comparison of development of RH among three groups whose starting caloric 
prescription is rooted in 1) weight on admission only 2) combination of weight on admission and 
intake prior and 3) intake prior to admission only.  Additionally, rate of weight gain among 
groups may garner useful information for practice.  
Further inquiry to refine the relationship between psychiatric state, resting energy 
expenditure, and RH is needed.  A potential next step would be direct measurement of anxiety 
using validated anxiety scales in a prospective cohort.  Additional investigation of common 
psychiatric co-morbid diagnoses, such as OCD and depression, was lacking in the present study 
and could be of important consideration.   
Summary  
 Variations in clinical practice with regards to length of stay, phosphorus supplementation, 
use of NG feedings, and caloric prescription (Schwartz et al., 2008) are indicative of a need for 
more definitive research into what individual or cumulative factors lead to greatest chance of RH 
during the nutritional rehabilitation phase of treatment for AN.  Results of this study advance the 
knowledge of the risk of development of RH or changes in serum phosphorus levels in this 
population.  The factors identified provide insight into potential areas for monitoring and 
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individualized care plans for the prevention and management of the outcome.  Clinicians should 
consider use of NG feeding, weight gain during hospitalization, age on admission, and 
electrolyte values when evaluating frequency of phosphorus monitoring, use of phosphorus 
supplementation, and caloric prescription. However, the lack of robust predictive value of the 
model underscores the urgent need for further inquiry in this area.  Areas of investigation with 
regards to feeding methods, mediators of phosphorus pathophysiology, and psychiatric status 
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